Invited Faculty
  • Eric Morand
    Monash Univ.
    Australia
  • Professor Eric Morand graduated in Medicine from Monash University, trained in clinical rheumatology in Australia and at the Royal National Hospital for Rheumatic Diseases, UK and took his PhD at Monash University. His laboratory research focusses on glucocorticoid-induced proteins in the immune system, and his clinical research on systemic lupus erythematosus. He founded the Lupus Clinic at Monash Health, and the Asia Pacific Lupus Collaboration, which developed and validated the Lupus Low Disease Activity State (LLDAS) endpoint. He led the TULIP2 trial of anifrolumab in SLE, resulting in its regulatory approval in multiple jurisdictions.
    His awards include the William E Paul Distinguished Innovator Award of the Lupus Research Alliance, New York, and the Eveyln V Hess Award of the Lupus Foundation of America. In 2021 he was inducted into the Honour Roll of Monash University and in 2022 as a Fellow of the Australian Academy of Health and Medical Sciences.
    Research & Clinical Focus

    systemic lupus erythematosus

    glucocorticoids

    biomarkers

    outcome measures

    • Date Time Room Session Title Lecture Title
    May 17 13:50-14:10 Room Grand Ballroom 105 [Study Group Session] Asia Pacific Lupus Collaboration (APLC) Study Group Session Scientific outcomes from the Asia Pacific Lupus Collaboration - From endpoint validation to survival factors
    May 20 11:00-11:30 Room Auditorium [Plenary Session 5] Clinical Challenges: Diagnosis and Outcome Measures Challenges in measuring clinical outcomes in SLE